COVID-19 antibodies persist at least 9 months after infection
In a new study from the University of Padua and Imperial College London, researchers found antibody levels remain high nine months after SARS-CoV-2 infection,...
Why do some people get severe COVID-19? The nose may know
The body's first encounter with SARS-CoV-2, the virus behind COVID-19, happens in the nose and throat, or nasopharynx.
In a new study from Boston Children's...
This existing drug could inhibit COVID-19 virus, study finds
In a new study from the University of Chicago, researchers found that the drug masitinib may be effective in treating COVID-19.
They found the drug...
COVID-19 may lead to a new wave of diabetes
In a new study from Boston Children's Hospital, researchers found a new long-term health concern in patients hospitalized with COVID-19—an increase in high blood...
Pfizer vaccine can provide 88% protection against Delta variant with TWO doses
In a new study from Public Health England and elsewhere, researchers found that Pfizer's coronavirus vaccine provides surprisingly robust protection against the highly infectious...
COVID-19 causes recurrent blood clots in a man’s arm
In a recent study published in the journal Viruses, researchers report the first instance of COVID-19 triggering a rare recurrence of potentially serious blood...
Heart disease remains #1 killer in U.S. indefinitely due to long-term COVID-19 impact
In a new report from the U.S Centers for Disease Control and Prevention, researchers found heart disease and stroke continue to kill more people...
This plant extract may help treat COVID-19
In a new study from Denmark, Germany and Hong Kong, researchers found that extracts from the artemisia annua plant may fight against the SARS-CoV-2...
‘You’re not bulletproof’: 50-year-old COVID survivor urges caution, vaccination after nearly dying from virus
Three months ago, doctors told her she would die from rapidly progressing COVID-19. Now recovering, a 50-year-old Michigan woman is cautioning others and urging...
Take your best shot: Which SARS-CoV-2 vaccine should you get?
Vaccine hesitancy continues to be a hurdle in the development of widespread immunity within the U.S. population as the COVID-19 pandemic enters its second...